Ixekizumab for the Treatment of Psoriasis: A Review of Phase III Trials (Q26766567)

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

author name string

Benjamin Farahnik

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kourosh Beroukhim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Tian Hao Zhu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Michael Abrouk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Rasnik Singh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Kristina Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

Tina Bhutani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

John Koo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

language of work or name

English

0 references

publication date

March 2016

0 references

published in

Dermatology and therapy

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

page(s)

25-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

Circulating Th17, Th22, and Th1 cells are increased in psoriasis

31 May 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

IL-17 family cytokines and the expanding diversity of effector T cell lineages

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Social impact of the burden of psoriasis: effects on patients and practice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Anti-IL-17 phase II data for psoriasis: A review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Biologic fatigue in psoriasis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Monoclonal antibody humanness score and its applications

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Targeting IL-17 in psoriasis: from cutaneous immunobiology to clinical application

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Role of IL-17 in psoriasis and psoriatic arthritis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

gammadelta T cells: an important source of IL-17.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Isotype selection in antibody engineering

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Psoriasis prevalence among adults in the United States

28 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappaB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Serum and tissue levels of IL-17 in different clinical subtypes of psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Nail involvement as a predictor of concomitant psoriatic arthritis in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

IL-17 receptor and its functional significance in psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13555-016-0102-0

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4799032

A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses

28 November 2018

1 reference

12 December 2020

Synergistic effects of vascular IL-17 and TNFalpha may promote coronary artery disease

1 reference

12 December 2020

Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease

1 reference

12 December 2020

Interleukin-17 promotes angiogenesis and tumor growth

1 reference

12 December 2020

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

1 reference

12 December 2020

10.1007/S13555-016-0102-0

Identifiers

DOI

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

31 May 2020

1020857620

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json

31 May 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26910853%20AND%20SRC:MED&resulttype=core&format=json